U.S. Markets closed

Enzymotec Ltd. (ENZY)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
7.10+0.25 (+3.65%)
At close: 4:00PM EDT
People also watch
EVGNKMDAMDWDADHDEPZM
Full screen
Previous Close6.85
Open6.85
Bid0.00 x
Ask0.00 x
Day's Range6.85 - 7.10
52 Week Range5.20 - 9.32
Volume168,396
Avg. Volume15,328
Market Cap162.91M
Beta0.98
PE Ratio (TTM)-36.98
EPS (TTM)-0.19
Earnings DateAug 7, 2017 - Aug 11, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.83
Trade prices are not sourced from all markets
  • GlobeNewswire27 days ago

    Enzymotec Chief Financial Officer to Step Down

    MIGDAL HA'EMEQ, Israel, June 28, 2017-- Enzymotec Ltd., a developer, manufacturer and marketer of innovative bio-active lipid ingredients and medical foods, today announced that Mr. Oren Bryan, will be ...

  • Enzymotec Ltd. :ENZY-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017
    Capital Cubelast month

    Enzymotec Ltd. :ENZY-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017

    Categories: Yahoo FinanceGet free summary analysis Enzymotec Ltd. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Enzymotec Ltd. – Sensient Technologies Corporation, Abbott Laboratories and Teva Pharmaceutical Industries Limited Sponsored ADR (SXT-US, ABT-US and TEVA-US) that have also reported for this period. Highlights Summary numbers: ... Read more (Read more...)

  • Weakness Seen in Enzymotec (ENZY) Estimates: Should You Stay Away?
    Zackslast month

    Weakness Seen in Enzymotec (ENZY) Estimates: Should You Stay Away?

    Enzymotec (ENZY) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.